Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1.
about
Lynch syndrome from a surgeon perspective: retrospective study of clinical impact of mismatch repair protein expression analysis in colorectal cancer patients less than 50 years oldTesting women with endometrial cancer for lynch syndrome: should we test all?Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instabilityObservational Study: Familial Relevance and Oncological Significance of Revised Bethesda Guidelines in Colorectal Patients That Have Undergone Curative ResectionClinical genetic counselling for familial cancers requires reliable data on familial cancer risks and general action plans.Challenges and pitfalls in HNPCC screening by microsatellite analysis and immunohistochemistry.Some aspects of molecular diagnostics in Lynch syndrome.Economic and Practical Factors in Diagnosing HNPCC Using Clinical Criteria, Immunohistochemistry and Microsatellite Instability Analysis.Current and emerging trends in Lynch syndrome identification in women with endometrial cancer.Screening for mismatch repair deficiency in colorectal cancer: data from three academic medical centers.Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation Carriers.Underdiagnosis of Lynch syndrome involves more than family history criteriaMolecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.Complementary analysis of microsatellite tumor profile and mismatch repair defects in colorectal carcinomas.The genetic basis of Lynch syndrome and its implications for clinical practice and risk management.Clinical and molecular analysis of hereditary non-polyposis colorectal cancer in Chinese colorectal cancer patients.Clinicopathological and genetic features of Chinese hereditary nonpolyposis colorectal cancer (HNPCC).hMLH1 promoter methylation and BRAF mutations in high-frequency microsatellite instability colorectal cancers not fulfilling the revised Bethesda guidelines.Clinical application of genetics in management of colorectal cancer.The revised Bethesda guidelines: extent of utilization in a university hospital medical center with a cancer genetics programIdentification of patients at-risk for Lynch syndrome in a hospital-based colorectal surgery clinic.When is molecular genetic testing for colorectal cancer indicated?Identification of patients at risk for hereditary colorectal cancerMismatch repair protein expression in colorectal cancer.CLINICAL MANAGEMENT OF FAMILIES WITH HEREDITARY COLORECTAL CANCER SYNDROMES.Current and evolving strategies for colorectal cancer screening.Impact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing.Referral for cancer genetics consultation: a review and compilation of risk assessment criteriaDiagnosing Lynch syndrome: is the answer in the mouth?The germline MLH1 K618A variant and susceptibility to Lynch syndrome-associated tumorsRisk Factors Associated with Colorectal Cancer in a Subset of Patients with Mutations in MLH1 and MSH2 in Taiwan Fulfilling the Amsterdam II Criteria for Lynch SyndromeAbnormal oral mucosal light reflectance: a new clinical marker of high risk for colorectal cancerIdentification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer.Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome.ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing.Hereditary aspects of colon cancerMolecular testing for microsatellite instability and its value in tumor characterization.Hereditary non-polyposis colon cancerComparison of the clinical prediction model PREMM(1,2,6) and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer.Genetic detection of Chinese hereditary nonpolyposis colorectal cancer.
P2860
Q21256711-993C53F4-E901-4E2A-B9CB-5914820CC900Q24562824-03E580E9-8718-45C5-BF29-20D537CA2A69Q24618618-7083281C-ED6C-468B-A3AE-A4A7291AF173Q27315851-04010A40-197A-4B8B-95E4-EC80424B587CQ30974845-21DFA25C-9087-4E75-9F74-17D4007927D2Q33208352-DC41F2BD-AEF6-47EC-8B9C-10C621C8BAE8Q33722604-8F61F3B8-433F-46F3-8ED8-CB91EE27D452Q33732330-83107960-7D1F-4976-871C-A20535A51CDBQ33738168-3D17D4D2-57C7-44D8-A3BE-7257151BBF20Q33775296-A0A42061-FC38-41C6-A061-BEB0D6B64FB6Q33807931-DEC7350D-3FE8-4533-B276-33C47ECC986AQ33889119-0E281E62-BF02-4153-97E8-374C861C8337Q33904639-5D6085A7-CECE-4753-9AE6-49101472F46DQ34013017-D78D3945-5873-4CF4-90A9-62EFF8DED371Q34081267-3943BBE0-9971-4559-A11F-2D5B711D7BB3Q34099201-A2DBEEA7-122B-46A7-9FE0-8C8F94825BB9Q34174654-9E2D0B76-24E4-45FC-8E20-AA9AE8CBFFF7Q34221477-C33293C8-9F5E-43E2-9AD2-1F43250EFEF2Q34378719-686AD40D-5233-487E-A6EF-44F89DD33053Q34380045-816D9E1E-4D25-4472-9385-292A89BA55E3Q34591199-7B12BB4C-9064-425B-A170-F929EEA8C529Q34619340-93D7CB50-BD94-4B0E-B3DB-5A62CFA4468BQ34652530-A19E7FB1-05C8-4F6C-AF37-2D9A39FE0E3DQ35057393-50682CAD-CEB2-4C3F-9596-6FEC9F0748A8Q35087269-A29CDF3D-7A68-4741-ACDE-90C4335042E2Q35148786-863B62FC-95A1-4273-BC2E-42A25B94C497Q35235483-0EC29B6B-E3F9-41AE-BE8E-5900D11E28B6Q35444793-B0F4BE74-B83C-4813-A4B3-213D49083E41Q35596120-E49D7FCD-922D-4F21-AF05-5EC76A54AC45Q35608600-035CA403-4E68-45D1-B034-39C5DA74C044Q35656237-BE393E95-74EC-4703-9F26-32CE3D807F9FQ35760885-975500AD-4D36-4FE2-9883-4C8FCFF87D3BQ35760971-ADC4231A-4E8A-4F23-8479-5AD1FC0FA075Q35799369-ABA1F208-6B06-48C6-A0B2-98F8C31FE27EQ36081155-AB6093EB-E4CD-41C3-B76E-9CA6A36C754EQ36101834-87A421C0-C841-4930-86DC-277B1DF123D1Q36192733-3E897B2F-E00F-4313-B7B6-63C62CF61DD2Q36198294-F55C0EBF-FDE5-424B-AF7E-CAF0D2EC18DCQ36315747-EFFD9EB9-C94B-4F83-A9A4-EEDEBEF74018Q36474384-1CA0F8BF-8C7F-4910-9D7F-13815227E613
P2860
Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Sensitivity and specificity of ...... ed mutations in MSH2 and MLH1.
@ast
Sensitivity and specificity of ...... ed mutations in MSH2 and MLH1.
@en
type
label
Sensitivity and specificity of ...... ed mutations in MSH2 and MLH1.
@ast
Sensitivity and specificity of ...... ed mutations in MSH2 and MLH1.
@en
prefLabel
Sensitivity and specificity of ...... ed mutations in MSH2 and MLH1.
@ast
Sensitivity and specificity of ...... ed mutations in MSH2 and MLH1.
@en
P2093
P2860
P356
P1476
Sensitivity and specificity of ...... ed mutations in MSH2 and MLH1.
@en
P2093
P2860
P304
P356
10.1136/JMG.37.9.641
P407
P577
2000-09-01T00:00:00Z